Postgraduate Course – Paradigm Shifts In Hepatology: Rethinking Conventional Wisdom

Part I: 8:30 am – Noon | Part II: 1:30 pm – 4:30 pm | Audience Q&A: 4:30 pm – 5:30 pm

Program Chairs: Raymond T. Chung, MD, FAASLD; Kimberly A. Brown, MD, FAASLD; Lawrence Friedman, MD, FAASLD

Continuing Education Credits: Up to 7.00 CME Credits Offered | Up to 7.00 ABIM MOC Points Offered | Up to 7.00 Contact Hours Offered

Program Agenda

Part I (On Demand)

Scheduled in live program for 8:30 am – 12:00 pm
Welcome and Introductions (5 min)
Session I: The Changing Practice of Hepatology

• The Evolution of Personalized Medicine in Hepatology Practice; Scott L. Friedman
• Toward a Biopsy Free World; Elliot Tapper
• Care of Patients with Advanced Liver Disease: A Team Sport (include frailty, Pall Care, Psychiatry); Victor Navarro
• Measuring the Unmeasurable: Incorporating Quality Metrics into the Care of Patients with Cirrhosis; Michael Volk
• Virtual Care: The Future is Now (focus on COVID-19); Sanjeev Arora

Session II: New Concepts in Metabolic and Toxic Liver Disease

• NAFLD Beyond Obesity (Incorporate lean NAFLD and Pediatric, Maternal/Fetal relationship); Kathleen Corey
• Rethinking Management of Alcohol-associated Liver Disease: The Other Fatty Liver Epidemic (include post-bariatric risk for AUD); Mack Mitchell
• The Gut-Liver Axis: What the Clinician Needs to Know; Anna Mae Diehl

Session III: The Immune System and the Liver

• Evolving Management of Autoimmune Liver Disease: Beyond Conventional Immunosuppression; Marlyn Mayo
• Liver Disease Related to Cancer Immunotherapy; Michael Dougan
• DILI as an Immune Disorder of the Liver: Implications for Management; Paul Watkins

Part II (On Demand)

Scheduled in live program for 1:30 pm – 4:30 pm
Session IV: Rethinking Complications of Liver Disease

• Acute-on-Chronic Liver Failure: Evolving Concepts; Jacqueline O’Leary
• Portal Hypertension: Revisiting our Principles; Guadalupe Garcia-Tsao
• Hemostasis and Thrombosis in Chronic Liver Disease: New Concepts in Management (PVT, management of progressive liver disease, management of procedures); Stephen Caldwell
• Evolving Strategies to Optimize Outcome in Liver Transplantation; Julie Heimbach
• Transformation of the HCC Management Paradigm; Jorge Marrero

Session V: Revising Our Goals in Viral Hepatitis

• Hepatitis C: Cure, Yes, but We’re Not Done Yet; David Thomas
• HBV and HDV: Can We Now Talk About Cure?; Anna S. Lok
• Other Viruses Affecting the Liver, including SARS-CoV-2; Jordan Feld
  

Audience Q&A (Live)

Scheduled in live program for Saturday, November 14 from 4:30 pm – 5:30 pm